Last reviewed · How we verify
Androstenolone Acetate — Competitive Intelligence Brief
unknown
prasterone acetate
Other
Live · refreshed every 30 min
Target snapshot
Androstenolone Acetate (prasterone acetate). Androstenolone Acetate works by interacting with androgen receptors in the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Androstenolone Acetate TARGET | prasterone acetate | unknown | prasterone acetate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Androstenolone Acetate · 8629129 · Formulation · US
- — Androstenolone Acetate · 8957054 · Method of Use · US
- — Androstenolone Acetate · 8268806 · Formulation · US
Sponsor landscape (prasterone acetate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Androstenolone Acetate CI watch — RSS
- Androstenolone Acetate CI watch — Atom
- Androstenolone Acetate CI watch — JSON
- Androstenolone Acetate alone — RSS
- Whole prasterone acetate class — RSS
Cite this brief
Drug Landscape (2026). Androstenolone Acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/prasterone-acetate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing